HTG Molecular Diagnostics to Present at H.C. Wainwright’s 23rd Annual Global Investment Conference

September 8, 2021 at 4:10 PM EDT

TUCSON, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwright’s 23rd Annual Global Investment Conference, being held September 13th – 15th, 2021.

Details for the presentation are below:

Date: 7:00 a.m. ET
Time: Monday, September 13th, 2021

Management will also be available for 1x1 meetings. If you would like to request a meeting, please email

About HTG:
HTG is focused on NGS-based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. Its mission is to empower precision medicine. To learn more, visit


Ashley Robinson
Phone: (617) 430-7577

Primary Logo

Source: HTG Molecular Diagnostics, Inc.